The inherited diseases of hemoglobin are an emerging global health burden

Blood

Volumn 115, Issue 22, 2010, Pages 4331-4336

  Weatherall, David J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THALASSEMIA; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; DEMOGRAPHY; DEVELOPING COUNTRY; EMERGENCY CARE; EPIDEMIOLOGICAL DATA; HEMATOLOGIC DISEASE; HEMOGLOBIN DISEASE; HUMAN; INFANT MORTALITY; POPULATION GENETICS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; THALASSEMIA MAJOR; EPIDEMIOLOGY; GENETICS; HEALTH; HEMOGLOBINOPATHY; NEWBORN;

DEVELOPING COUNTRIES; EPIDEMIOLOGIC FACTORS; GENETICS, POPULATION; HEMOGLOBINOPATHIES; HUMANS; INFANT, NEWBORN; WORLD HEALTH;

EID: 77953952024     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-01-251348     Document Type: Review

References (32)

1. Christianson A, Howson CP, Modell B. March of Dimes Global Report on Birth Defects. New York, NY: March of Dimes Birth Defects Foundation; 2006.
2. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480-487.
3. Malaria Atlas Project, MAP. http://www.map.ox.ac.uk. Accessed April 20, 2010.
4. Livingstone FB. Frequencies of Hemoglobin Variants. New York, NY: Oxford University Press; 1985.
5. Weatherall DJ, Clegg JB. The Thalassaemia Syndromes. 4th ed. Oxford, United Kingdom: Blackwell Science; 2001.
6. Weatherall DJ, Akinyanju O, Fucharoen S, Olivieri NF, Musgrove P. Inherited disorders of hemoglobin. In: Jamison DT, Breman JG, Measham AR, et al, eds. Disease Control Priorities in Developing Countries. 2nd ed. New York, NY: Oxford University Press and the World Bank; 2006:663-680.
7. de Silva S, Fisher CA, Premawardhena A, et al. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group. Lancet. 2000;355(9206):786-791.
8. Colah R, Gorakshakar A, Phanasgaonkar S, et al. Epidemiology of beta-thalassaemia in Western India: mapping the frequencies and mutations in sub-regions of Maharashtra and Gujarat [published online ahead of print March 3, 2010]. Br J Haematol. doi:10.1111/j.1365-2141.2010.08131.
9. Bittles AH, Mason WM, Greene J, Rao NA. Reproductive behavior and health in consanguineous marriages. Science. 1991;252(5007):789-794.
10. Weatherall DJ. Genetic variation and susceptibility to infection: the red cell and malaria. Br J Haematol. 2008;141(3):276-286.
11. Williams TN. Red blood cell defects and malaria. Mol Biochem Parasitol. 2006;149(2):121-127.
12. Briet OJ, Galappaththy GN, Konradsen F, Amerasinghe PH, Amerasinghe FP. Maps of the Sri Lanka malaria situation preceding the tsunami and key aspects to be considered in the emergency phase and beyond. Malar J. 2005;4:8.
13. Williams TN, Mwangi TW, Wambua S, et al. Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet. 2005;37(11):1253-1257.
14. Penman BS, Pybus OG, Weatherall DJ, Gupta S. Epistatic interactions between genetic disorders of hemoglobin can explain why the sickle-cell gene is uncommon in the Mediterranean. Proc Natl Acad Sci U S A. 2009;106(50):21242- 21246.
15. O'Donnell A, Premawardhena A, Arambepola M, et al. Interaction of malaria with a common form of severe thalassemia in an Asian population. Proc Natl Acad Sci U S A. 2009;106:18716-18721.
16. Williams TN, Maitland K, Bennett S, et al. High incidence of malaria in alpha-thalassaemic children. Nature. 1996;383:522-525.
17. Population Reference Bureau. World Population Data Sheet. http://www.prb.org. Accessed April 16, 2010.
18. Serjeant GR, Serjeant BE. Sickle Cell Disease. 3rd ed. Oxford, United Kingdom: Oxford University Press; 2001.
19. Williams TN, Uyoga S, Macharia A, et al. Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet. 2009;374(9698):1364-1370.
20. Kulozik AE, Wainscoat JS, Serjeant GR, et al. Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. Am J Hum Genet. 1986;39(2):239-244.
21. Kar BC, Satapathy RK, Kulozik AE, et al. Sickle cell disease in Orissa State, India. Lancet. 1986;2(8517):1198-1201.
22. Rahimi Z, Merat A, Gerard N, Krishnamoorthy R, Nagel RL. Implications of the genetic epidemiology of globin haplotypes linked to the sickle cell gene in southern Iran. Hum Biol. 2006;78(6):719-731.
23. Weatherall DJ. Thalassemia as a global health problem: recent progress towards its control in the developing countries. Ann N Y Acad Sci. In press.
24. Chernoff AI, Minnich V, Na-Nakorn S, Tuchinda S, Kashamsant C, Chernoff RR. Studies on hemoglobin E, I: the clinical, hematologic, and genetic characteristics of the hemoglobin E syndromes. J Lab Clin Med. 1956;47:455-489, 490-498.
25. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia: molecular biology and clinical medicine. Hemoglobin. 1997;21:299-319.
26. Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C, Weatherall DJ. Studies in haemoglobin E beta-thalassaemia. Br J Haematol. 2008;141(3):388-397.
27. Stamatoyannopoulos G. Problems of screening and counselling in the hemoglobinopathies. In: Motulsky AG, Lenz W, eds. IVth International Congress on Birth Defects. Vienna, Austria: Excerpta Medica; 1973:268-276.
28. Canali S, Corbellini G. Lessons from anti-thalassemia campaigns in Italy, before prenatal diagnosis. Med Secoli. 2002;14(3):739-771.
29. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64(1-2 suppl):97-106.
30. World Health Organization. Genomics and World Health. Geneva, Switzerland: WHO; 2002.
31. WHO-TIF Meeting. Management of Haemoglobin Disorders. Report of a joint WHO-TIF Meeting, Nicosia, Cyprus. Geneva, Switzerland: WHO; 2007.
32. Global Burden of Disease. http://www.globalburden. org. Accessed April 1, 2010.